MadeMed prints a per-month rate and the full prepayment on the same tile, so the billing cycle is not left to be worked out — and then contradicts itself in the hero of one of its four product pages.
What MadeMed charges
Sermorelin: $169/mo — 6-month plan, billed $1014 every 6 months; the quarterly tab on the same page prints $179/month billed $537 every 3 months
Sermorelin: $99/mo — 6-month plan, billed $594 every 6 months; the quarterly tab on the same page prints $109/month billed $327 every 3 months
NAD+: $199/mo — 6-month plan, billed $1194 every 6 months; the quarterly tab was not opened on this page
NAD+: $269/mo — 6-month plan, billed $1614 every 6 months; the same page hero prints "From $279/mo"
MadeMed is not a paid partner; this link may earn a commission if that changes. Full disclosure.
By Nora Castellan, Standards EditorUpdated September 2026
A shell that looks exactly like a missing page
This seller is a single-page application, so its served HTML is one shell for every address it answers.
The nonsense-path control returned a success code and a body the same size as the home page, which on a site like this proves nothing in either direction.
Rendered, the control produces navigation and a footer and no product at all, and so does one of the addresses in the seller's own sitemap.
The four pages that do carry products render many times longer, and that difference, not the status code, is what every claim on this row rests on.
The plan tab, the prepayment and the hero
Each product tile carries a rate per month and, immediately beneath it, the full amount charged and how often it is charged.
Both plan tabs were opened rather than only the one the page selects for you, so the cheaper and the dearer option are both on the record.
On the nasal product the hero and the tile print different rates as the starting figure, and both are stored rather than reconciled into one.
Nothing on this row was arrived at by dividing a prepayment by the number of months it covers.
Coverage that is answered per product, not per company
The state question is asked and answered separately on each product page, and the answers do not agree with one another.
One product names a count and then lists by name every state it does not serve, so a reader can settle the question without starting an intake.
Another publishes a shorter enumerated list, so a reader eligible for one line may not be eligible for the next.
No single coverage figure is recorded for the company, because the company does not publish one.
Labs required, labs not included
A blood test is required before prescribing on two of the four products, and the seller says so plainly.
The buyer obtains that test at an outside laboratory or uploads a recent result, so the cost sits outside the published rate.
Recent results from any certified laboratory are accepted, which is a genuine convenience and still not an inclusion.
The dispensing pharmacy is named on one product page only, inside a collapsed answer, and described generically everywhere else.
Who it's for
Readers who want the prepayment total printed beside the monthly rate.
Buyers choosing between an injection and a sublingual tablet of the same compound.
Shoppers who would rather be told which states are excluded than left to guess.
Anyone comparing an injectable and a nasal route for the same cellular-energy product.
Who should look elsewhere
Readers who need one coverage answer that holds for the whole company.
Buyers who do not want to arrange and pay for a blood test.
Shoppers looking for the wider peptide menu; this seller prices two tracked compounds.
Anyone who wants a registered company name published on the site.
Strengths
Prints a per-month plan rate and the full prepayment beside it on the same tile, so the billing cycle is not hidden
Names the pharmacy behind its nasal line rather than saying only that a US pharmacy is used
Answers its state question with a count and then lists the states it does not serve
Publishes both an injectable and a sublingual route for the same compound at separately stated rates
Trade-offs
The nasal spray page prints one figure in its hero and a different one on the plan tile
The state list differs by product, so there is no single coverage answer for the company
Requires a blood test the buyer arranges and pays for at an outside lab
Publishes no corporate entity, so there is no registered company a reader can look up
How we verified this
Read every page cited on this row as rendered text in a real browser, not as served HTML, because several sellers in this pass ship the figure in by script and serve a bare currency sign.
Fired a nonsense-path control at this host in the same run and judged it on the rendered document rather than on its status code or its byte count.
Joined every text node before scanning for a currency sign, so a figure split across nested elements could not read as an absence.
Clicked every collapsed accordion on the pages read, because pharmacy names, state answers and lab conditions hid inside them on most sellers checked this pass.
Read each figure inside its own card or panel rather than by nearness to a compound name, on pages that price weight-loss lines beside peptide lines.
Recorded the seller's own published figure and never divided a multi-month total into a monthly one.
Screened this seller in the live federal warning-letter record by entity and by brand, with a known-good positive control and a nonsense negative control fired in the same run.
Read the company column of every returned record rather than accepting a full-text match, and attached no letter unless the letter itself named this seller's own domain.
Opened both plan tabs on the two products that offer them, so the recorded rate is not merely the one the page pre-selects.
Compared the hero line against the plan tile on every product page and recorded the conflict where the two disagreed.
Read each product's state answer separately rather than assuming one answer covered the company.
A provider to compare MadeMed against
Trellis Vitality
Trellis Vitality frames its program around body-composition tracking rather than scale weight, pairing NAD+, glutathione and tesamorelin with at-home biomarker panels and a 90-day re-test, and names its dispensing pharmacy, VialsRX in Houston, by address.